Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 5
1991 25
1992 32
1993 40
1994 65
1995 125
1996 127
1997 132
1998 138
1999 173
2000 154
2001 152
2002 146
2003 170
2004 116
2005 108
2006 103
2007 90
2008 93
2009 90
2010 99
2011 109
2012 124
2013 156
2014 123
2015 129
2016 146
2017 101
2018 117
2019 89
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

3,065 results
Results by year
Filters applied: . Clear all
Page 1
SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.
E Hermosilla V, Salgado G, Riffo E, Escobar D, Hepp MI, Farkas C, Galindo M, Morín V, García-Robles MA, Castro AF, Pincheira R. E Hermosilla V, et al. Mol Oncol. 2018 Jun;12(7):1026-1046. doi: 10.1002/1878-0261.12308. Epub 2018 May 21. Mol Oncol. 2018. PMID: 29689621 Free PMC article.
Cyclin E Deregulation and Genomic Instability.
Teixeira LK, Reed SI. Teixeira LK, et al. Adv Exp Med Biol. 2017;1042:527-547. doi: 10.1007/978-981-10-6955-0_22. Adv Exp Med Biol. 2017. PMID: 29357072 Review.
Cyclin D as a therapeutic target in cancer.
Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Musgrove EA, et al. Nat Rev Cancer. 2011 Jul 7;11(8):558-72. doi: 10.1038/nrc3090. Nat Rev Cancer. 2011. PMID: 21734724 Review.
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.
Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Osborne C, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O. Martinez-Soria N, et al. Cancer Cell. 2018 Oct 8;34(4):626-642.e8. doi: 10.1016/j.ccell.2018.08.015. Cancer Cell. 2018. PMID: 30300583 Free PMC article.
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
Bayard Q, Meunier L, Peneau C, Renault V, Shinde J, Nault JC, Mami I, Couchy G, Amaddeo G, Tubacher E, Bacq D, Meyer V, La Bella T, Debaillon-Vesque A, Bioulac-Sage P, Seror O, Blanc JF, Calderaro J, Deleuze JF, Imbeaud S, Zucman-Rossi J, Letouzé E. Bayard Q, et al. Nat Commun. 2018 Dec 7;9(1):5235. doi: 10.1038/s41467-018-07552-9. Nat Commun. 2018. PMID: 30531861 Free PMC article.
Atypical cyclins: the extended family portrait.
Quandt E, Ribeiro MPC, Clotet J. Quandt E, et al. Cell Mol Life Sci. 2020 Jan;77(2):231-242. doi: 10.1007/s00018-019-03262-7. Epub 2019 Aug 16. Cell Mol Life Sci. 2020. PMID: 31420702 Free PMC article. Review.
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.
Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S. Martín-Garcia D, et al. Blood. 2019 Feb 28;133(9):940-951. doi: 10.1182/blood-2018-07-862151. Epub 2018 Dec 11. Blood. 2019. PMID: 30538135 Free PMC article.
Plant A-type cyclins.
Chaubet-Gigot N. Chaubet-Gigot N. Plant Mol Biol. 2000 Aug;43(5-6):659-75. doi: 10.1023/a:1006303100592. Plant Mol Biol. 2000. PMID: 11089868 Review.
3,065 results
Jump to page
Feedback